Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
British Journal of Pharmacology
|
October 2, 2021
Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist
Qiuyu Zheng, Wenju Lu, Han Yan, et al.
Signal Transduction and Targeted Therapy
|
March 9, 2023
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
Shuxin Liang, Changlei Bao, Zi Yang, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 8, 2022
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension
Changlei Bao, Shuxin Liang, Ying Han, et al.
Respiratory Research
|
August 17, 2023
Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model
Meidan Kuang, Yilin Chen, Yue Xing, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
May 31, 2020
A novel rat model of pulmonary hypertension induced by mono treatment with SU5416
Yuqin Chen, Meidan Kuang, Shiyun Liu, et al.
Thrombosis Research
|
August 21, 2022
Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension
Jiyuan Chen, Jinrui Miao, Dansha Zhou, et al.
British Journal of Pharmacology
|
November 3, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats
Chenting Zhang, Wenju Lu, Xiaoyun Luo, et al.
Biochemical Pharmacology
|
March 11, 2022
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells
Jian Wang, Wenyan Liu, Wenju Lu, et al.
Physiological Reports
|
December 31, 2024
Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats
Zizhou Zhang, Yaru Liang, Shaocong Mo, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 14, 2020
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension
Chenting Zhang, Tingting Zhang, Wenju Lu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
British Journal of Pharmacology
|
October 2, 2021
Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist
Qiuyu Zheng, Wenju Lu, Han Yan, et al.
Signal Transduction and Targeted Therapy
|
March 9, 2023
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
Shuxin Liang, Changlei Bao, Zi Yang, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 8, 2022
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension
Changlei Bao, Shuxin Liang, Ying Han, et al.
Respiratory Research
|
August 17, 2023
Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model
Meidan Kuang, Yilin Chen, Yue Xing, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
May 31, 2020
A novel rat model of pulmonary hypertension induced by mono treatment with SU5416
Yuqin Chen, Meidan Kuang, Shiyun Liu, et al.
Thrombosis Research
|
August 21, 2022
Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension
Jiyuan Chen, Jinrui Miao, Dansha Zhou, et al.
British Journal of Pharmacology
|
November 3, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats
Chenting Zhang, Wenju Lu, Xiaoyun Luo, et al.
Biochemical Pharmacology
|
March 11, 2022
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells
Jian Wang, Wenyan Liu, Wenju Lu, et al.
Physiological Reports
|
December 31, 2024
Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats
Zizhou Zhang, Yaru Liang, Shaocong Mo, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 14, 2020
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension
Chenting Zhang, Tingting Zhang, Wenju Lu, et al.
Page
of 5